Jafron Biomedical Co. Ltd. | Mutual Funds

Mutual Funds that own Jafron Biomedical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
750,000
0.71%
750,000
0.92%
12/31/2017
460,181
0.44%
384,799
1.41%
12/31/2017
390,000
0.37%
390,000
1.23%
12/31/2017
305,912
0.28%
305,912
2.79%
12/31/2017
First State Cinda Leaders Growth Equity Fund
207,714
0.2%
207,714
0.61%
12/31/2017
206,000
0.2%
206,000
1.18%
12/31/2017
193,202
0.18%
114,100
2.06%
12/31/2017
153,300
0.14%
153,300
0.62%
12/31/2017
86,100
0.08%
86,100
0.16%
12/31/2017
75,800
0.07%
51,900
0.36%
12/31/2017

About Jafron Biomedical Co.

View Profile
Address
98 Keji 6th Road
Zhuhai Guangdong 519085
China
Employees -
Website http://www.jafron.com
Updated 07/08/2019
Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include single-use blood perfusion devices, blood perfusion machines, disposable plasma bilirubin adsorbers, and DX-10 blood purification machines. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China.